Genetic polymorphisms and risk of coronary artery disease

Seminars in Thrombosis and Hemostasis

Volumn 24, Issue 3, 1998, Pages 245-250

  Murata, Mitsuru ^a   Kawano, Koichi ^b   Matsubara, Yumiko ^a   Ishikawa, Kyozo ^b   Watanabe, Kiyoaki ^a   Ikeda, Yasuo ^a  

^a KEIO UNIVERSITY   (Japan)

^b KYORIN UNIVERSITY   (Japan)

Author keywords

Coronary artery disease; Glycoprotein Ib IX complex; Platelets; Polymorphisms; Risk factors

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 9; COLLAGEN; FIBRINOGEN RECEPTOR; FIBRINOLYTIC FACTOR; GLYCOPROTEIN IB; MEMBRANE PROTEIN; THROMBOCYTE RECEPTOR; VASOACTIVE AGENT; VON WILLEBRAND FACTOR;

ANGINA PECTORIS; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY THROMBOSIS; CORONARY RISK; ETHNIC GROUP; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; JAPAN; PRIORITY JOURNAL; RISK FACTOR; SHEAR STRESS; THROMBOCYTE MEMBRANE;

EID: 0031868874     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995849     Document Type: Conference Paper

References (45)

1. Cambien F, Poirier O, Lecerf L, Evans A, Cambou J-P. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359:641-644
2. Di Minno G, Gradone E, Margaglione M. Clinical relevance of polymorphic markers of arterial thrombosis. Thromb Haemostas 1997;78:462-466
3. Goldbourt U, Neufeld HN. Genetic aspects of arteriosclerosis. Arteriosclerosis 1986;6:357-377
4. Miletich JP, Prescott SM, White R, Majerus PW, Bovill EG. Inherited predisposition to thrombosis. Cell 1993;72:477-480
5. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohen PF. Blood platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation 1991;84: 613-617
6. Ikeda Y, Handa M, Kawano K, et al. The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. J Clin Invest 1991;87:1234-1240
7. Ikeda Y, Murata M, Goto S. von Willebrand factor-dependent shear-induced platelet aggregation: Basic mechanisms and clinical implications. Ann NY Acad Sci 1997;811:323-336
8. Tokuue J, Hayashi J, Hata Y, Nakahara K, Ikeda Y. Enhanced platelet aggregability under high shear stress after treadmill exercise in patients with effort angina. Thromb Haemostas 1996; 75:833-837
9. Nichols TC, Bellinger DA, Johnson TA, Lamb MA, Griggs TR. Von Willebrand's disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries. Circ Res 1986; 59:15-26
10. Yao SK, Ober JC, Garfinkel LI, et al. Blockade of platelet membrane glycoprotein Ib receptors delays intracoronary thrombogenesis, enhances thrombolysis, and delays coronary artery reocclusion in dogs. Circulation 1994;89:2822-2828
11. Jansson JH, Nilsson TK, Johnson O. Von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J 1991;66:351-355
12. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-641
13. Lopez JA. The platelet glycoprotein Ib-IX complex. Blood Coag Fibrinolysis 1994;5:97-119
14. Murata M, Furihata K, Ishida F, et al. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness. Blood 1992;79: 3086-3090
15. Ishida F, Furihata K, Ishida K, et al. The largest variant of platelet glycoprotein Ibαhas four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine 145. Blood 1995;86:1356-1360
16. Murata M, Matsubara Y, Kawano K, et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation. 1997;96:3281-3286.
17. Weiss EJ, Bray PF, Tayback M, et al. A polymorphism of platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 1996;334:1090-1094
18. A1/A2 polymorphism of platelet glycoprotein IIIa and risks of myocardial infarction, stroke, and venous thrombosis. Lancet 1997;349:385-388
19. Kunicki TJ, Kritzik M, Annis DS, Nugent DJ. Hereditary variation in platelet integrin α2β1 density is associated with two silent polymorphisms in the α2 gene coding sequence. Blood 1997;89: 1939-1943
20. Humphries SE, Ye S, Talmud P, Bara L, Wilhelmsen L, Tiret L. European Atherosclerosis Research Study: Genotype at the fibrinogen locus (G-455-A beta gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe: Evidence for gender-genotype-environment interaction. Arterioscler Thromb Vasc Biol 1995;15:96-104
21. Wang XL, Wang J, McCredie RM, Wilcken DEL. Polymorphisms of factor V, factor VII, and fibrinogen genes - Relevance to severity of coronary artery disease. Arterioscler Thromb Vasc Biol 1997;17:246-251
22. Poort SR, Rosendaal FR, Restina PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703
23. Makris M, Preston FE, Beauchamp NJ, et al. Co-inheritance of the 20210A allele of the prothrombin gene increases the thrombotic risk in subjects with familial thrombosis (abstr). Thromb Haemostas 1997; Suppl 165
24. Rosendaal FR, Siscovick DS, Schwartz SM, et al. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women. Blood 1997;90:1747-1750
25. Isshiki I, Murata M, Wantabe R, et al. Frequencies of prothrombin 20210G→A mutation may be different among races. Studies on Japanese populations with various forms of thrombotic disorders and healthy subjects. Blood Coagulation and Fibrinolysis 1998;9(1):105-106
26. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-1134
27. Bernardi F, Marchetti G, Pinotti M, et al. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 1996;16: 72-76
28. Heywood DM, Mansfield MW, Grant PJ. Factor VII polymorphism, factor VII: C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus. Thromb Haemostas 1996;75:401-406
29. Kohler HP, Catto AJ, Stickland MH, et al. Association of a common polymorphism in the a-subunit gene of factor XIII with myocardial infarction and stroke: Interaction with PAI-1 levels and PAI-1 4G/5G genotype (abstr). Thromb Haemostas 1997; Suppl 770
30. Mansfield MW, Stickland MH, Grant PJ. Plasminogen activator inhibitor-1 (PAI-1) promotor polymorphism and coronary artery disease in non-insulin-dependent diabetes. Thromb Haemostas 1995;74:1032-1034
31. Eriksson P, Kallin B, van t'Hooft FM, Bavhenolm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor I gene is associated with myocardial infarction. Proc Natl Acad Sci USA 1995;92:1851-1855
32. Norlund L, Holm J, Zoeller B, Oehlin A-K. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemostas 1997;77:248-251
33. Wilson PWF, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease: A meta-analysis. Arterioscler Thromb Vasc Biol 1996;16:1250-1255
34. Serrato M, Marian AJ. A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary artery disease. J Clin Invest 1995;96:3005-3008
35. Antikainen M, Murtomaki S, Syvanne M, et al. The Gln-Arg 191 polymorphism of the paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns. J Clin Invest 1996;98:883-885
36. Zama T, Murata M, Matsubara Y, et al. An 192 Arg variant of the human paraoxonase (HUMPONA) gene polymorphisms is associated with the increased risk for coronary artery disease in the Japanese. Arterioscler Thromb Vasc Biol 1997;17:3565-3569
37. Kang SS, Passen EL, Ruggie N, Wong PW, Sora H. Thermolabile defect of methylene-tetrahydrofolate reductase in coronary artery disease. Circulation 1993;88:1463-1469
38. Morita H, Takagi J, Kurihara H, et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 1997;95:2032-2036
39. Nakai K, Itoh C, Miura Y, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in the Japanese. Circulation 1994;90:2199-2202
40. Kario K, Kanai N, Saito K, et al. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996;93:1630-1633
41. Tiret L, Bonnardeaux A, Poirier O, et al. Synergistic effects of angiotensin-converting enzyme and angiotensin-II type I receptor gene polymorphisms on risk of myocardial infarction. Lancet 1994;344:910-913
42. Badenhop RF, Wang XL, Wilcken DEL. Association between an angiotensinogen microsatellite marker in children and coronary events in their grandparents. Circulation 1996;93:2092-2096
43. Wang XL, Sim AS, Badenhop RF, McCredie RM, Wilcken DEL. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nature Med 1996;2:41-45
44. Matsubara Y, Murata M, Kawano K, et al. Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and it's relation to serum lipid levels. Arterioscler Thromb Vasc Biol 1997;17:3006-3012
45. Zama T, Murata M, Ono F, et al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Japanese patients with various forms of thrombosis and normal individuals. Int J Hematol 1996;65:71-78